Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli
| Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli |
| Pubbl/distr/stampa | Norfolk, England : , : Caister Academic Press, , [2015] |
| Descrizione fisica | 1 online resource (474 p.) |
| Disciplina | 615.372 |
| Soggetto topico |
Vaccines - Research
Drug development |
| Soggetto genere / forma | Electronic books. |
| ISBN | 1-910190-04-7 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Current Books of Interest; Preface; Part I: Innovative Technologies and Approaches in Vaccine Research; 1: Deep Sequencing in Vaccine Research, Development and Surveillance ; Impact of DNA sequencing on vaccines research and development; Deep sequencing potential to transform vaccinology; 2: New Bioinformatics Algorithms Applied to Deep Sequencing Projects ; Introduction; Better understating of host and pathogen genomes; Computational approaches to study adaptive immune responses; Better understanding of transcriptome
Epigenomics: understanding of inheritable chemical changesMetagenomics: finding new pathogens and strains; Bioinformatics challenges; 3: Comparative Genomics Approaches for Tracking the Emergence and Spread of Disease-associated Bacteria; Background; Comparative genomics of disease-associated bacteria; Assays for identification of disease-associated bacteria based on insights from comparative genomics; Conclusions; 4: Quantitative Proteomics in Vaccine Research; Introduction; Quantitative proteomics based on gel electrophoresis; Quantitative proteomics based on differential mass tag Label-free technologies and targeted proteomicsMass spectrometry for viral vaccinology; Proteomic technology for vaccine development ; Combining proteomics and system biology to improve vaccines; Concluding remarks; 5: Structural Biology in Vaccine Research; Introduction; Experimental mapping and computational prediction of epitopes; Examples of structural vaccinology for bacterial and viral pathogens; Concluding remarks and future directions; 6: Cellular Screens to Interrogate the Human T- and B-cell Repertoires and Design Better Vaccines ; Introduction Generation of naive B- and T-cell repertoires7: Novel Strategies of Vaccine Administration: The Science Behind Epidermal and Dermal Immunization; Introduction; The skin layers; Skin antigen-presenting cells and other players in vaccination; Principles and methods in skin immunization; Vaccine formulation and immunity; Immunological advantage of epidermal and dermal immunization; 8: Toll-like Receptors as Targets to Develop Novel Adjuvants; Introduction; Innate immunity; TLR-based adjuvants in high-priority vaccines; Lessons learned from studies of TLR agonists as adjuvants Safety considerations of TLR agonistsChallenges for the next decade; 9: The Importance of Cell-mediated Immunity for Bacterial Vaccines ; Introduction; T-cell responses to bacterial infection; Targeting cellular immunity for novel anti-bacterial vaccine design; 10: T-cell-inducing Vaccines; Introduction; How can we measure T-cell responses?; Technologies for inducing T-cell responses by vaccination; Heterologous prime-boost immunization; Successful clinical development of T-cell vaccines; 11: Exploiting the Mutanome for Personalized Cancer Immunotherapy Cancer mutations as therapeutic targets |
| Record Nr. | UNINA-9910460918103321 |
| Norfolk, England : , : Caister Academic Press, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli
| Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli |
| Pubbl/distr/stampa | Norfolk, England : , : Caister Academic Press, , [2015] |
| Descrizione fisica | 1 online resource (474 p.) |
| Disciplina | 615.372 |
| Soggetto topico |
Vaccines - Research
Drug development |
| ISBN | 1-910190-04-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Current Books of Interest; Preface; Part I: Innovative Technologies and Approaches in Vaccine Research; 1: Deep Sequencing in Vaccine Research, Development and Surveillance ; Impact of DNA sequencing on vaccines research and development; Deep sequencing potential to transform vaccinology; 2: New Bioinformatics Algorithms Applied to Deep Sequencing Projects ; Introduction; Better understating of host and pathogen genomes; Computational approaches to study adaptive immune responses; Better understanding of transcriptome
Epigenomics: understanding of inheritable chemical changesMetagenomics: finding new pathogens and strains; Bioinformatics challenges; 3: Comparative Genomics Approaches for Tracking the Emergence and Spread of Disease-associated Bacteria; Background; Comparative genomics of disease-associated bacteria; Assays for identification of disease-associated bacteria based on insights from comparative genomics; Conclusions; 4: Quantitative Proteomics in Vaccine Research; Introduction; Quantitative proteomics based on gel electrophoresis; Quantitative proteomics based on differential mass tag Label-free technologies and targeted proteomicsMass spectrometry for viral vaccinology; Proteomic technology for vaccine development ; Combining proteomics and system biology to improve vaccines; Concluding remarks; 5: Structural Biology in Vaccine Research; Introduction; Experimental mapping and computational prediction of epitopes; Examples of structural vaccinology for bacterial and viral pathogens; Concluding remarks and future directions; 6: Cellular Screens to Interrogate the Human T- and B-cell Repertoires and Design Better Vaccines ; Introduction Generation of naive B- and T-cell repertoires7: Novel Strategies of Vaccine Administration: The Science Behind Epidermal and Dermal Immunization; Introduction; The skin layers; Skin antigen-presenting cells and other players in vaccination; Principles and methods in skin immunization; Vaccine formulation and immunity; Immunological advantage of epidermal and dermal immunization; 8: Toll-like Receptors as Targets to Develop Novel Adjuvants; Introduction; Innate immunity; TLR-based adjuvants in high-priority vaccines; Lessons learned from studies of TLR agonists as adjuvants Safety considerations of TLR agonistsChallenges for the next decade; 9: The Importance of Cell-mediated Immunity for Bacterial Vaccines ; Introduction; T-cell responses to bacterial infection; Targeting cellular immunity for novel anti-bacterial vaccine design; 10: T-cell-inducing Vaccines; Introduction; How can we measure T-cell responses?; Technologies for inducing T-cell responses by vaccination; Heterologous prime-boost immunization; Successful clinical development of T-cell vaccines; 11: Exploiting the Mutanome for Personalized Cancer Immunotherapy Cancer mutations as therapeutic targets |
| Record Nr. | UNINA-9910787429503321 |
| Norfolk, England : , : Caister Academic Press, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli
| Advanced vaccine research : methods for the decade of vaccines / / edited by Fabio Bagnoli and Rino Rappuoli |
| Pubbl/distr/stampa | Norfolk, England : , : Caister Academic Press, , [2015] |
| Descrizione fisica | 1 online resource (474 p.) |
| Disciplina | 615.372 |
| Soggetto topico |
Vaccines - Research
Drug development |
| ISBN | 1-910190-04-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Contents; Contributors; Current Books of Interest; Preface; Part I: Innovative Technologies and Approaches in Vaccine Research; 1: Deep Sequencing in Vaccine Research, Development and Surveillance ; Impact of DNA sequencing on vaccines research and development; Deep sequencing potential to transform vaccinology; 2: New Bioinformatics Algorithms Applied to Deep Sequencing Projects ; Introduction; Better understating of host and pathogen genomes; Computational approaches to study adaptive immune responses; Better understanding of transcriptome
Epigenomics: understanding of inheritable chemical changesMetagenomics: finding new pathogens and strains; Bioinformatics challenges; 3: Comparative Genomics Approaches for Tracking the Emergence and Spread of Disease-associated Bacteria; Background; Comparative genomics of disease-associated bacteria; Assays for identification of disease-associated bacteria based on insights from comparative genomics; Conclusions; 4: Quantitative Proteomics in Vaccine Research; Introduction; Quantitative proteomics based on gel electrophoresis; Quantitative proteomics based on differential mass tag Label-free technologies and targeted proteomicsMass spectrometry for viral vaccinology; Proteomic technology for vaccine development ; Combining proteomics and system biology to improve vaccines; Concluding remarks; 5: Structural Biology in Vaccine Research; Introduction; Experimental mapping and computational prediction of epitopes; Examples of structural vaccinology for bacterial and viral pathogens; Concluding remarks and future directions; 6: Cellular Screens to Interrogate the Human T- and B-cell Repertoires and Design Better Vaccines ; Introduction Generation of naive B- and T-cell repertoires7: Novel Strategies of Vaccine Administration: The Science Behind Epidermal and Dermal Immunization; Introduction; The skin layers; Skin antigen-presenting cells and other players in vaccination; Principles and methods in skin immunization; Vaccine formulation and immunity; Immunological advantage of epidermal and dermal immunization; 8: Toll-like Receptors as Targets to Develop Novel Adjuvants; Introduction; Innate immunity; TLR-based adjuvants in high-priority vaccines; Lessons learned from studies of TLR agonists as adjuvants Safety considerations of TLR agonistsChallenges for the next decade; 9: The Importance of Cell-mediated Immunity for Bacterial Vaccines ; Introduction; T-cell responses to bacterial infection; Targeting cellular immunity for novel anti-bacterial vaccine design; 10: T-cell-inducing Vaccines; Introduction; How can we measure T-cell responses?; Technologies for inducing T-cell responses by vaccination; Heterologous prime-boost immunization; Successful clinical development of T-cell vaccines; 11: Exploiting the Mutanome for Personalized Cancer Immunotherapy Cancer mutations as therapeutic targets |
| Record Nr. | UNINA-9910820979003321 |
| Norfolk, England : , : Caister Academic Press, , [2015] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccine research
| Vaccine research |
| Pubbl/distr/stampa | Tehran : , : Pasteur Institute of Iran, , 2014- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Vaccines - Research
Vaccins - Recherche |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910411655503321 |
| Tehran : , : Pasteur Institute of Iran, , 2014- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccine research
| Vaccine research |
| Pubbl/distr/stampa | Tehran : , : Pasteur Institute of Iran, , 2014- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Vaccines - Research
Vaccins - Recherche |
| Soggetto genere / forma |
Periodical
periodicals. Periodicals. Périodiques. |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996353848703316 |
| Tehran : , : Pasteur Institute of Iran, , 2014- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine
| Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (210 p.) |
| Disciplina | 338.47615372 |
| Collana | Publication IOM |
| Soggetto topico |
Vaccines - Research
Immunization |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-24677-4
9786610246779 0-309-58152-4 0-585-14491-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""
""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" ""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions"" ""Public-Private Sector Interactions"" |
| Record Nr. | UNINA-9910456053203321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine
| Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (210 p.) |
| Disciplina | 338.47615372 |
| Collana | Publication IOM |
| Soggetto topico |
Vaccines - Research
Immunization |
| ISBN |
1-280-24677-4
9786610246779 0-309-58152-4 0-585-14491-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""
""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" ""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions"" ""Public-Private Sector Interactions"" |
| Record Nr. | UNINA-9910778679103321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine
| Vaccine supply and innovation [[electronic resource] /] / Division of Health Promotion and Disease Prevention, Institute of Medicine |
| Pubbl/distr/stampa | Washington, D.C., : National Academy Press, 1985 |
| Descrizione fisica | 1 online resource (210 p.) |
| Disciplina | 338.47615372 |
| Collana | Publication IOM |
| Soggetto topico |
Vaccines - Research
Immunization |
| ISBN |
1-280-24677-4
9786610246779 0-309-58152-4 0-585-14491-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""
""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities"" ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS"" ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY"" ""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions"" ""Public-Private Sector Interactions"" |
| Record Nr. | UNINA-9910811951603321 |
| Washington, D.C., : National Academy Press, 1985 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
